Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

  • Ralph DeFronzo, Triplitt, Cersosimo
  • Vascular Health and Risk Management, August 2010, Taylor & Francis
  • DOI: 10.2147/vhrm.s4852

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2147/vhrm.s4852